Virginia Litwin

7.1k total citations · 1 hit paper
34 papers, 4.3k citations indexed

About

Virginia Litwin is a scholar working on Molecular Biology, Immunology and Biophysics. According to data from OpenAlex, Virginia Litwin has authored 34 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Immunology and 11 papers in Biophysics. Recurrent topics in Virginia Litwin's work include Single-cell and spatial transcriptomics (17 papers), Cell Image Analysis Techniques (11 papers) and Biosimilars and Bioanalytical Methods (8 papers). Virginia Litwin is often cited by papers focused on Single-cell and spatial transcriptomics (17 papers), Cell Image Analysis Techniques (11 papers) and Biosimilars and Bioanalytical Methods (8 papers). Virginia Litwin collaborates with scholars based in United States, United Kingdom and Switzerland. Virginia Litwin's co-authors include Kirsten Nagashima, Paul J. Maddon, Graham P. Allaway, William A. Paxton, Tatjana Dragic, Richard A. Koup, JOHN P. MOORE, Yaoxing Huang, Charmagne Cayanan and Lewis L. Lanier and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Virginia Litwin

33 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1996 2.6k citations Tatjana Dragic, Virginia Litwin et al. Nature profile →

Peers

Countries citing papers authored by Virginia Litwin

Since Specialization

Citations

This map shows the geographic impact of Virginia Litwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Litwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Litwin more than expected).

Fields of papers citing papers by Virginia Litwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Litwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Litwin. The network helps show where Virginia Litwin may publish in the future.

Co-authorship network of co-authors of Virginia Litwin

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Litwin. A scholar is included among the top collaborators of Virginia Litwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Litwin. Virginia Litwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using Spectral Flow Cytometry for CAR T-Cell Clinical Trials: Game Changing Technologies Enabling Novel Therapies 2024 ·International Journal of Molecular Sciences ·Thomas C. Beadnell, Susmita Jasti, (unknown), Bruce H. Davis, Virginia Litwin	0
2	Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines 2024 ·Cytometry Part B Clinical Cytometry ·Sara A. Monaghan, Steven Eck, Silvia T. Bunting, (unknown), Robert J. Durso, (unknown), Amanda Hays, Andrea Illingworth, (unknown), (unknown), Megan McCausland, Thomas W. McCloskey, (unknown), Min Shi, Paul K. Wallace, Virginia Litwin, Wolfgang Kern, George Deeb, (unknown), Horatiu Olteanu	3
3	The Evolution of Single-Cell Analysis and Utility in Drug Development 2021 ·The AAPS Journal ·Shibani Mitra‐Kaushik, (unknown), Jennifer J. Stewart, Cherie Green, Virginia Litwin, (unknown)	14
4	Best practices for optimization and validation of flow cytometry‐based receptor occupancy assays 2020 ·Cytometry Part B Clinical Cytometry ·(unknown), Yongliang Sun, Thomas W. McCloskey, (unknown), Thomas McIntosh, Katharine D. Grugan, (unknown), Nathan Standifer, Cherie Green, Virginia Litwin, Jennifer J. Stewart	5
5	Flow cytometric method transfer: Recommendations for best practice 2020 ·Cytometry Part B Clinical Cytometry ·Maciej Cabanski, Teri Oldaker, Jennifer J. Stewart, Nithianandan Selliah, (unknown), Cherie Green, Virginia Litwin, Alessandra Vitaliti	10
6	Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses 2020 ·Cytometry Part B Clinical Cytometry ·Ghanashyam Sarikonda, Mélissa Mathieu, (unknown), Anil Pahuja, (unknown), Piotr Pierog, Paul C. Trampont, Vilma Decman, Susan D. Reynolds, Laïla‐Aïcha Hanafi, Yongliang Sun, Steven Eck, Michael N. Hedrick, Jennifer J. Stewart, Shabnam Tangri, Virginia Litwin, Naveen Dakappagari	25
7	ICCS/ESCCA Consensus Guidelines to detect GPI‐deficient cells in Paroxysmal Nocturnal Hemoglobinuria (PNH) and related Disorders Part 4 – Assay Validation and Quality Assurance 2017 ·Cytometry Part B Clinical Cytometry ·Teri Oldaker, Liam Whitby, (unknown), Jeannine T. Holden, Paul K. Wallace, Virginia Litwin	23
8	Recommendations for the evaluation of specimen stability for flow cytometric testing during drug development 2015 ·Journal of Immunological Methods ·Lynette Brown, (unknown), Nicholas Jones, Jennifer J. Stewart, Stephanie Fraser, Kathy Howell, Yuanxin Xu, (unknown), (unknown), Wendy I. White, Peter J. O’Brien, Virginia Litwin	21
9	Flow cytometry in drug discovery and development 2011 ·Wiley eBooks ·Virginia Litwin, Philip Marder	4
10	Recommendations for the validation of flow cytometric testing during drug development: I instrumentation 2010 ·Journal of Immunological Methods ·(unknown), Lynette Brown, Jennifer J. Stewart, Yuanxin Xu, Virginia Litwin, (unknown)	39
11	Recommendations for the validation of flow cytometric testing during drug development: II assays 2010 ·Journal of Immunological Methods ·(unknown), Yuanxin Xu, Zhiyan Liang, Manjula Reddy, Dianna Wu, Virginia Litwin	87
12	Specificity of two anti‐class IHLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor 1996 ·Tissue Antigens ·Jenny E. Gumperz, Jacqueline C. M. Paterson, Virginia Litwin, Nicholas M. Valiante, Lewis L. Lanier, Peter Parham, (unknown)	10
13	HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 breakdown → 1996 ·Nature ·Tatjana Dragic, Virginia Litwin, Graham P. Allaway, (unknown), Yaoxing Huang, Kirsten Nagashima, Charmagne Cayanan, Paul J. Maddon, Richard A. Koup, JOHN P. MOORE, William A. Paxton	2625
14	Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer 1996 ·Journal of Virology ·Virginia Litwin, Kirsten Nagashima, (unknown), (unknown), (unknown), William C. Olson, Marc Alizon, Karl W. Hasel, Paul J. Maddon, Graham P. Allaway	18
15	The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. 1995 ·The Journal of Experimental Medicine ·Jenny E. Gumperz, Virginia Litwin, Joseph H. Phillips, Lewis L. Lanier, Peter Parham	437
16	NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. 1994 ·The Journal of Experimental Medicine ·Virginia Litwin, Jenny E. Gumperz, Peter Parham, Joseph H. Phillips, Lewis L. Lanier	301
17	Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. 1993 ·The Journal of Experimental Medicine ·Virginia Litwin, Jenny E. Gumperz, Peter Parham, Joseph H. Phillips, Lewis L. Lanier	149
18	Herpesviral Fc receptors and their relationship to the human Fc receptors 1992 ·Immunologic Research ·Virginia Litwin, Charles Grose	16
19	Cell surface expression of the Varicella-zoster virus glycoproteins and Fc receptor 1990 ·Virology ·Virginia Litwin, Mátyás Sándor, Charles Grose	43
20	Immunology of the Varicella-Zoster Virus Glycoproteins 1988 ·The Journal of Infectious Diseases ·Charles Grose, Virginia Litwin	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact